Spect is a telemedicine startup company that leverages artificial intelligence (AI) to diagnose eye diseases in patients. The startup business recently secured $3.5 million in new funding from investors to help accelerate the growth of its company and telemedicine platform.
Growing the Team and AI Capabilities
Support for Spect during the round was driven by investments from California-based venture capital (VC) firms Morado Ventures and AME Cloud. London-based corporate venture capital firm XTX Ventures and Munich-based angel group 10x also participated in the funding.